1431952-09-8

Basic information

• Product Name: 2-[2-(3-chlorophenyl)-4-(4-ethenylphenyl)-1H-imidazol-1-yl]-N-(propan-2-yl)acetamide
• Synonyms: 2-[2-(3-chlorophenyl)-4-(4-ethenylphenyl)-1H-imidazol-1-yl]-N-(propan-2-yl)acetamide
• CAS NO: 1431952-09-8
• Molecular Weight: 379.889
• Mol File: 1431952-09-8.mol

Chemical Properties

• CAS DataBase Reference: 2-[2-(3-chlorophenyl)-4-(4-ethenylphenyl)-1H-imidazol-1-yl]-N-(propan-2-yl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[2-(3-chlorophenyl)-4-(4-ethenylphenyl)-1H-imidazol-1-yl]-N-(propan-2-yl)acetamide(1431952-09-8)
• EPA Substance Registry System: 2-[2-(3-chlorophenyl)-4-(4-ethenylphenyl)-1H-imidazol-1-yl]-N-(propan-2-yl)acetamide(1431952-09-8)

Safety Data

• Hazardous Substances Data: 1431952-09-8(Hazardous Substances Data)

Upstream product

• 1431952-07-6 2-[4-(4-bromophenyl)-2-(3-chlorophenyl)-1H-imidazol-1-yl]-N-(propan-2-yl)acetamide 
• 7486-35-3 tri-n-butyl(vinyl)tin 
• 1431952-05-4 4-(4-bromophenyl)-2-(3-chlorophenyl)-1H-imidazole 
• 99-73-0 para-bromophenacyl bromide 
• 25412-62-8 3-chlorobenzimidamide 

Downstream Products

• 1431952-10-1 2-{2-(3-chlorophenyl)-4-[4-(2-hydroxyethyl)phenyl]-1H-imidazol-1-yl}-N-(propan-2-yl)acetamide 

Relevant articles and documents

AZOLE DERIVATIVE

The present invention provides agents for treating or preventing diseases such as mood disorder, anxiety disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastrointestinal disease, drug addiction, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, head injury, inflammation, immune-related disease, alopecia, and so forth. Specifically, the invention provides azole derivatives represented by general formula (I), or pharmaceutically acceptable salts thereof that have an antagonistic action against the arginine-vasopressin (AVP) V1b receptor: